showed that abrogating JAK/STAT1 signaling in donor T cells could ameliorate GVHD and that transplantation of Stat1-deficient donor cells resulted in enhanced protection in the small intestine and colon (57). The gene discussed is STAT1; the disease is graft versus host disease.